Aims/hypothesis Screening programmes for type 2 diabetes inevitably find more people at high risk of developing diabetes than people with undiagnosed prevalent diabetes. We describe the incidence of diabetes for risk groups according to advancement in a screening process. Methods In 2001-2006, a diabetes screening programme based on the Danish diabetes risk score and measures of HbA 1c and glucose was carried out in Danish general practices. The present study includes 13,249 individuals with low diabetes risk scores and 22,726 with high diabetes risk scores but no diabetes according to WHO 1999 criteria. Seven incremental levels of diabetes risk were defined and followed for incident diabetes recorded in the Danish National Diabetes Register until December 2012. For each group, cumulative diabetes incidence was calculated. Incidence rates and rate ratios were estimated by Poisson regression analyses. Results After 10 years of follow-up 1,164 new diabetes cases were registered. Incidence rates were 1.0, 4.2, 14.5, 28.8 and 52.6 per 1,000 person-years in individuals at low risk and in those with normal glucose tolerance, impaired fasting glucose, impaired glucose tolerance and one diabetic glucose value, respectively. For each step in the screening algorithm, the risk of developing diabetes was higher than in the previous step. Conclusions/interpretation The risk of developing clinical diabetes in people who screen negative for diabetes depends on the level of risk stratification at screening, even at lower risk levels. This risk increases markedly in the presence of impaired glucose regulation. These results can inform policy recommendations concerning prevention strategies following screening.
There is strong evidence that progression to diabetes is preventable with intensive lifestyle modification or pharmacological interventions in individuals with IGT [1] [2] [3] [4] [5] . It remains unclear whether a similar effect is also achievable in those with IFG or intermediate HbA 1c .
Regarding healthcare planning, there is a surprising scarcity of data on diabetes incidence in the general population. A marked difference is seen between incidence rates based on self-reported or register-based diagnosed diabetes (ranging from around 0.5 to 10 per 1,000 person-years depending on age) [6] [7] [8] and incidence rates based on sequentially repeated diagnostic testing (ranging from around 7 to 20 per 1,000 person-years) [9] [10] [11] [12] [13] . A meta-analysis found that the progression rate to diabetes was 40-75 per 1,000 person-years in individuals with IFG or IGT [14] , giving annualised relative risks of diabetes development for the different dysglycaemic groups of between 5 and 12 [15] . When individuals with IFG and IGT are identified by a highrisk screening programme, though, it appears that the risk of incident diabetes is higher than that found in general population-based studies [16] . This indicates that the evidence on diabetes incidence from classic population-based studies may provide unrealistic estimates for healthcare policy making such as rescreening strategies.
In most screening programmes, the diagnostic test (fasting blood glucose [FBG] , OGTT or HbA 1c ) is preceded by a questionnaire-based risk assessment which serves to focus the diagnostic test on individuals most at risk. This process of high-risk screening or case-finding/opportunistic screening for diabetes, however, also identifies people who have high risk scores but who do not have impaired glucose regulation. Clinically relevant evidence on the differentiated risk of developing diabetes in such everyday screening situations is lacking and might be essential to guide physicians on how to advise their patients.
We aimed to examine the difference in incidence of clinical diabetes as registered in the Danish National Diabetes Register between groups at several incremental levels of increasing diabetes risk, identified during the screening programme of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Denmark study.
Methods
Study population The ADDITION-Europe study is a population-based study with the overall aim to evaluate whether screening and subsequent optimised intensive treatment of diabetes and associated risk factors improve the prognosis for individuals with undiagnosed type 2 diabetes [17] . The study was initiated in Denmark and also included centres in the UK and the Netherlands. In Denmark the study was conducted in general practices in five counties. General practitioners participating in the study were randomised to provide standard care or intensive pharmacological and nonpharmacological treatment of people with screen-detected diabetes. Screening for diabetes took place in 2001-2006 in 190 general practices in which all those aged 40-69 years and without known diabetes received a diabetes risk score questionnaire (the Danish diabetes risk score) [18] .
A pilot study was conducted in five general practices prior to initiation of the ADDITION-Denmark study. One aim of this pilot study was to enable cut-off levels (concerning HbA 1c , random blood glucose [RBG] and FBG) for advancing in the stepwise screening programme. In the ADDITIONDenmark study, the screening procedure consisted of four steps ( Fig. 1) : based on the Danish diabetes risk score, 28,035 people were identified as having a high risk of diabetes and underwent measurements of RBG and HbA 1c . If RBG was <5.5 mmol/l and HbA 1c was <5.8% (40 mmol/mol), no further glucose measurements were performed. If RBG was ≥5.5 mmol/l and HbA 1c was <5.8% (40 mmol/mol), FBG was measured. If this FBG was <5.6 mmol/l, no further tests were carried out; if, however, the FBG measurement was between 5.6 and 6.1 mmol/l, 2 h blood glucose (2hBG) was measured after a 75 g OGTT. If HbA 1c was ≥5.8% (40 mmol/ mol), FBG and 2hBG were measured on a second day. Diabetes was defined by the 1999 WHO criteria using capillary blood glucose [19] when RBG was ≥11.1 mmol/l, FBG was ≥6.1 mmol/l or 2hBG was ≥11.1 mmol/l. To be included in the interventional part of the ADDITIONEurope study this initial diabetic value had to be confirmed by an OGTT, on a separate day, as 'clinical diabetes'. In order to establish a group at low risk of diabetes, a subgroup (n = 32, 894) was asked to return their risk score questionnaire regardless of their score. This identified 13,249 people with a low diabetes risk (<5 points on the risk score) [20] .
On the basis of how far they advanced in the programme, those who completed the screening programme and were not diagnosed with screen-detected clinical diabetes were classified into seven groups of increasing diabetes risk (Fig. 1) .
& The first group had a low diabetes risk (risk score <5); no blood glucose measurements were therefore carried out (n = 13,249).
The following risk groups had a risk score ≥5:
& Moderate diabetes risk was defined as RBG <5.5 mmol/l and HbA 1c <5.8% (40 mmol/mol); no further glucose measurements were done (n = 13,037). & Elevated diabetes risk was defined as 5.5≤ RBG <11.1 mmol/l, HbA 1c <5.8% (40 mmol/mol) and FBG <5.6 mmol/l; 2hBG was not measured (n = 4,220).
In the following high-risk groups an OGTT with measurement of FBG and 2hBG defined the glucose tolerance status.
& High diabetes risk with normal glucose tolerance (NGT) was defined as FBG <5.6 mmol/l and 2hBG <7.8 mmol/l (n = 2,628). & IFG was defined as 5.6 mmol/l≤ FBG <6.1 mmol/l and 2hBG <7.8 mmol/l (n = 913). & IGT was defined as FBG <6.1 mmol/l and 7.8 mmol/l≤ 2hBG <11.1 mmol/l (n = 1,306). (Isolated IGT was defined as FBG <5.6 mmol/l and 7.8 mmol/l≤ 2hBG <11.1 mmol/l, n = 765; combined IFG and IGT was defined as 5.6 mmol/l≤ FBG <6.1 mmol/l and 7.8 mmol/l ≤ 2hBG <11.1 mmol/l, n = 541).
& The group with one diabetic blood glucose measurement that was not confirmed on the second test had RBG ≥11.1 mmol/l or one measurement of FBG ≥6.1 mmol/l or 2hBG ≥11.1 mmol/l (n = 622).
In total, 35,975 people were classified into seven groups. As individuals participating in our screening programme underwent several glucose measurements due to the screening algorithm, we excluded the two criteria based on blood glucose measurements in our data analysis in order to avoid cases representing false-positive inclusion of those with frequent measurements of blood glucose without having diabetes [22] . This gives a conservative (specific but not very sensitive) definition of diabetes.
Danish National Diabetes Register
Data analyses Individuals who participated in the screening programme were grouped into the seven risk groups shown in Fig. 1 . Data on these individuals were linked to the Danish National Diabetes Register updated to December 2012.
Baseline description data were summarised as medians (interquartile range [IQR]) or percentages. The cumulative risk of diabetes since the date of screening to the end of December 2012 was calculated for the seven groups. People were followed from study entry (screening) until the date of diabetes diagnosis, death or the last update of the diabetes register (31 December 2012), whichever occurred first. The corresponding incidence rates of diabetes and rate ratios, with the low-risk group as reference, were calculated using Poisson regression analyses, taking death before end of follow-up into account. A sensitivity analysis including age at screening in the model was performed, as age is a well-known, strong predictor of diabetes. To illustrate diabetes incidence over time, predicted incidence rates were modelled as a function of time since screening for each group. Statistical analyses were performed using SAS software (version 9.3; SAS Institute, Cary, NC, USA) and R (version 3.1.1; R Foundation for Statistical Computing, Vienna, Austria). The ADDITION study has been approved by the local Aarhus county ethics committees (reference number 20000183). The study complied with the Helsinki Declaration and participants gave written informed consent. Access to the Danish National Diabetes Register and the National Patient Register was approved by the Danish Data Protection Agency.
Results
The 35,975 screened individuals had a median age of 56.2 years (IQR 49.2-62.7) and 46.0% were men (Table 1) . During a median follow-up of 9.9 years (IQR 7.8-10.8), 1,164 people were registered with diabetes and 2,208 were censored due to death before diabetes diagnosis. Those censored through death were distributed evenly across groups. Censoring due to emigration is not considered relevant as the number of emigrants is very low.
The cumulative diabetes incidence was <1% in the group with low diabetes risk, based on the risk score questionnaire; 1-4% in intermediate diabetes risk groups, including high-risk NGT; and 12%, 22% and 34% in individuals with IFG, IGT and one diabetic glucose value, respectively ( Table 2 ). The overall diabetes incidence rate was 3.51 (95% CI 3.32, 3.72) per 1,000 person-years. The low-risk group had a diabetes incidence rate of 0.99 per 1,000 person-years. Diabetes incidence rates were two to four times higher in individuals with intermediate diabetes risk compared with those with low diabetes risk (Table 2) , whereas the rate ratios among those with impaired glucose regulation were markedly higher: 14.6, 29.1 and 53.1 for IFG, IGT and one diabetic glucose value, respectively ( Table 2 ). Adjusting for age did not change the rate ratios markedly (electronic supplementary material [ESM] Table 1 ). Figure 2 shows the predicted diabetes incidence rates as a function of time over 10 years, after screening for diabetes, for the seven risk groups separately. After 1 year, the riskstratified groups tended to cluster into four patterns (Fig. 2) . For those with one diabetic glucose value, the incidence was higher than for the other risk groups even though there was an exponential decrease during the follow-up period. For those with IFG or IGT, the incidence increased in the first 2 years after screening and subsequently decreased, whereas the incidence peaked after 5-6 years in the intermediate-risk groups. By contrast, diabetes incidence was more or less constant during the first 6 years in the lowest risk group. After 8 years of follow-up, there were only 19 diabetes cases in total, explaining the shapes of the curves and wide CIs at the end of the follow-up period.
Discussion
On the basis of linkage of the baseline risk classification from a stepwise screening study-the ADDITION-Denmark Study-with the Danish National Diabetes Register, we found that each incremental baseline risk level corresponded to a higher risk of register-based diabetes during a median of 10 years of follow-up. The incidence rate of register-based diabetes ranged from 1.0 (95% CI 0.8, 1.2) per 1,000 person-years in the low-risk group to 52.6 (95% CI 46.0, 60.1) among those with a single diabetic value at screening, not confirmed during a second OGTT. Hence, compared with the low-risk group, the risk of developing diabetes was more than fifty times higher in the group with one diabetic glucose value.
Targeted screening and case-finding programmes focused on high-risk individuals are increasingly common worldwide. Although the primary motivation and stated aim of these programmes are generally to identify people with prevalent undiagnosed diabetes, the process of screening also leads to identification of an increasing number of screen-negative (no undiagnosed diabetes present) people, who are nevertheless at various intermediate levels of increased diabetes risk. We followed a large group of people identified in a pragmatic stepwise screening programme in general practice in Denmark. Accordingly, we provide clinically relevant new evidence on the relative risk of diabetes for the graded risk groups identified by screening. As shown previously, 50% responded to the invitation, and of those who had risk scores ≥5, 77% attended the stepwise screening programme [20] . By comparison, 53% responded in the population-based Danish Inter99 study, which screened for diabetes and cardiovascular disease [23] . The Danish National Diabetes Register represents diagnostic practice in the real world. It is the best available diabetes register in Denmark, covering both primary care and hospitals, and it is nationwide, i.e. it covers all those with a Central Person Register number. The incidence of diabetes using registers will inevitably be different from that defined by glucose measures or HbA 1c . Hence, the diabetes incidence in the present study was lower than previously estimated by glucose measures in the ADDITION-Denmark study [16] ; similar tendencies appear when comparing estimates from studies with repeated OGTT measures with estimates from register-based studies [6] [7] [8] [9] [10] [11] [12] [13] . In general, diabetes registers are constructed according to in-and outpatient hospital diagnostic coding, reimbursement data, medical prescriptions and, to some extent, laboratory data. When comparing the Danish National Diabetes Register with a local Danish county diabetes register, both registers found a prevalence of diabetes of 4%, but only 63% were the same individuals [24] . The Danish National Diabetes Register is based on accessible national registers, which do not include laboratory results, as laboratory reporting systems vary between regions in Denmark. The local register used performance of HbA 1c measurement and values above 6.6% (47 mmol/mol) instead of ascertainment of blood glucose measures and chiropody for the diagnosis of diabetes.
The two main inclusion criteria in the Danish National Diabetes Register are ascertainment of five blood glucose values in 1 year and prescription of glucose-lowering drugs, closely followed by hospital diagnosis of diabetes in the National Patient Register [24, 25] . We excluded the two criteria on blood glucose measurements because the ADDITION-Denmark population was more likely than nonstudy populations to have frequent blood glucose A full explanation of the diabetes risk categories is given in the Methods/Study population section . Besides, poor adherence to medication is common in patients with type 2 diabetes, and a large proportion never initiate glucose-lowering treatment. These patients are not captured in the register [26] , but we have no reasons to believe that there may be a systematic bias according to baseline diabetes risk in the register. Hence, although the absolute incidence rates found in our study may underestimate the true incidence, the incidence rate ratios should be representative of the population in screened general practice. We found increasing diabetes incidence in people with IFG or IGT, which peaked after 2 years. This might to some extent reflect the follow-up of people with IFG or IGT after 1-3 years in accordance with national guidelines at the time [27, 28] , and this again might also have skewed the diabetes incidence due to diagnostic bias compared with lower risk groups. It is a limitation to the interpretation of the time-dependent incidence rates that it is unknown to us how the other risk groups were followed up and what happened after the third year. However, we believe that the relative risks in our study reflect diagnostic practice in everyday life. Diabetes incidence in the intermediate-risk groups increased over time and peaked after 5-6 years. The fact that diabetes incidence in the intermediaterisk groups was not constant indicates that those screened have been followed up, even though there were no guideline recommendations at that time for individuals without IFG or IGT. Regarding the lowest risk group, diabetes incidence was low and more or less constant during the follow-up period. This is an essential finding for future healthcare planning, indicating that people with low risk scores based on risk factors for diabetes and without glucose measures need no systematic re-screening.
The risk group with one diabetic glucose value must be close to the diabetic threshold in the natural history of developing diabetes. The diabetes incidence rate in this risk group was highest shortly after the time of screening and had no later peak. Generally, the incidence rates seem to decrease markedly and broader CIs are observed in the last time period after screening, being most pronounced from 7 to 10 years. This may be explained by depletion of susceptible people over time in a closed cohort, as the most susceptible will develop diabetes soon after screening, leaving the cohort with a larger proportion of less susceptible people.
Today, the diagnosis of diabetes can be based on both blood glucose and HbA 1c [29] . In the present study, the diagnosis of diabetes at screening and during follow-up was based on the WHO 1999 criteria, before the diagnostic use of HbA 1c was implemented in Denmark in 2012. How diagnostic practice in general practice might have changed since 2012 is unknown.
In our study the stratification into risk groups was based on the design of the screening algorithm. At present, a screening algorithm in Denmark would most probably be different, by using HbA 1c rather than FBG or 2hBG and giving the follow- [14] . Our results show that even below the cut-off levels for IFG and IGT, the presence of diabetes risk factors is related to a higher incidence of diabetes, indicating that our understanding and implementation of diabetes prevention strategies should move beyond the glucose-centric view and consider intermediate dysglycaemia as part of a concert of risk factors.
Our documentation of relative increased future diabetes risk, especially in people with impaired glucose regulation compared with lower stratification groups, stresses the need for regular follow-up (annually) and systematic lifestyle counselling in these risk groups, as real-life preventive programmes are effective, though effectiveness varies between programmes [30] . In people with elevated risk factors for diabetes but normal glucose regulation at the time of screening, the increased risk of future diabetes underlines a need for regular re-screening for diabetes. Based on our observed time-dependent incidence rates for diabetes we suggest 3 year intervals for re-screening of these intermediate-risk groups. However, as our study is limited by its registry linkage with risk of bias in that the different risk groups may have been seen differently for follow-up by their general practitioners, further studies are needed where all risk groups in a screening programme attend the same follow-up schedule. Our study furthermore asks for evidence of possible intervention strategies, i.e. lifestyle counselling, to prevent development of diabetes in individuals with high diabetes risk but normal or intermediate glucose regulation. As high-risk screening or systematic case finding is already commonly recommended, these individuals are being identified and guidance on how to advise them is needed.
Conclusions
The risk of future diabetes in people who screen negatively for diabetes depends on the level of risk stratification at screening: the higher the risk stratification at screening, the higher the risk of developing diabetes during 10 years. A very low incidence rate for people with low estimated diabetes risk based on risk factors alone indicates no need for rescreening at time-specific intervals, whereas groups with impaired glucose regulation have a significantly increased risk of short-term future diabetes. However, screen-negative individuals with normoglycaemia should not be ignored, as the diabetes incidence in this group increases during the first 5-6 years after screening. Although high-risk strategies differ and the results from this one cannot be extrapolated directly to other highrisk or case-finding strategies, the point of relatively increased risk of diabetes in graded risk groups applies generally. These results may support policy recommendations for prevention strategies following screening programmes.
